CRANIOPHARYNGIOMA - ENDOCRINE SEQUELAE OF TREATMENT

被引:56
作者
SKLAR, CA
机构
关键词
CRANIOPHARYNGIOMA; POSTOPERATIVE GROWTH; DIABETES INSIPIDUS; OBESITY;
D O I
10.1159/000120873
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Following complete surgical resection of a craniopharyngioma, combined anterior and posterior pituitary dysfunction is present in the majority of patients. Moreover, up to three-quarters of the patients will have deficits of four or more hormones. Postsurgery, obesity is common and can be part of a clinical syndrome which includes hyperphagia and normal growth despite GH deficiency. Radiotherapy with or without conservative surgery is associated with fewer endocrine disturbances. Normal growth and sexual development should be possible in most patients with the use of appropriate hormonal substitution therapy.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 21 条
[1]   OVEREATING AND OBESITY FROM DAMAGE TO A NORADRENERGIC SYSTEM IN BRAIN [J].
AHLSKOG, JE ;
HOEBEL, BG .
SCIENCE, 1973, 182 (4108) :166-169
[2]  
BLETHEN S L, 1987, Pediatrician, V14, P242
[3]  
BLUMBERG DL, 1989, PEDIATRICS, V83, P998
[4]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II, PROLACTIN, AND INSULIN IN 19 GROWTH-HORMONE DEFICIENT CHILDREN WITH EXCESSIVE, NORMAL, OR DECREASED LONGITUDINAL GROWTH AFTER OPERATION FOR CRANIOPHARYNGIOMA [J].
BUCHER, H ;
ZAPF, J ;
TORRESANI, T ;
PRADER, A ;
FROESCH, ER ;
ILLIG, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (19) :1142-1146
[5]   GROWTH-HORMONE TREATMENT IN CHILDREN WITH CRANIOPHARYNGIOMA - FINAL GROWTH STATUS [J].
BURNS, EC ;
TANNER, JM ;
PREECE, MA ;
CAMERON, N .
CLINICAL ENDOCRINOLOGY, 1981, 14 (06) :587-595
[6]  
CLAYTON PE, 1988, LANCET, V1, P642
[7]   CRANIOPHARYNGIOMA - ROLE OF INSULIN IN PROMOTING POSTOPERATIVE GROWTH [J].
COSTIN, G ;
KOGUT, MD ;
PHILLIPS, LS ;
DAUGHADAY, WH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 42 (02) :370-379
[8]   EFFECTS OF INSULIN AND GROWTH-HORMONE ON RELEASE OF SOMATOMEDIN BY ISOLATED RAT-LIVER [J].
DAUGHADAY, WH ;
PHILLIPS, LS ;
MUELLER, MC .
ENDOCRINOLOGY, 1976, 98 (05) :1214-1219
[9]  
FRADKIN JE, 1989, NEW ENGL J MED, V320, P640
[10]   RISK OF LEUKEMIA AFTER TREATMENT WITH PITUITARY GROWTH-HORMONE [J].
FRADKIN, JE ;
MILLS, JL ;
SCHONBERGER, LB ;
WYSOWSKI, DK ;
THOMSON, R ;
DURAKO, SJ ;
ROBISON, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (23) :2829-2832